Patents by Inventor Herbert Treutlein

Herbert Treutlein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic inhibitors of PCSK9
    Patent number: 11897868
    Abstract: This application relates to chemical compounds which may act as inhibitors of, or which may otherwise modulate the activity of, PCSK9, or a pharmaceutically acceptable salt, solvate, prodrug or polymorph thereof, and to compositions and formulations comprising such compounds, and methods of using and making such compounds. Compounds include compounds of Formula (I): wherein A, D and Q are described herein.
    Type: Grant
    Filed: June 30, 2021
    Date of Patent: February 13, 2024
    Assignee: CARDIO THERAPEUTICS PTY LTD
    Inventors: Herbert Treutlein, Jun Zeng, Ian Dixon, Ian James, James T. Palmer
  • HETEROCYCLIC INHIBITORS OF PCSK9
    Publication number: 20220002271
    Abstract: This application relates to chemical compounds which may act as inhibitors of, or which may otherwise modulate the activity of, PCSK9, or a pharmaceutically acceptable salt, solvate, prodrug or polymorph thereof, and to compositions and formulations comprising such compounds, and methods of using and making such compounds. Compounds include compounds of Formula (I): wherein A, D and Q are described herein.
    Type: Application
    Filed: June 30, 2021
    Publication date: January 6, 2022
    Inventors: Herbert TREUTLEIN, Jun ZENG, Ian DIXON, Ian JAMES, James T. PALMER
  • Heterocyclic inhibitors of PCSK9
    Patent number: 11091466
    Abstract: This application relates to chemical compounds which may act as inhibitors of, or which may otherwise modulate the activity of, PCSK9, or a pharmaceutically acceptable salt, solvate, prodrug or polymorph thereof, and to compositions and formulations comprising such compounds, and methods of using and making such compounds. Compounds include comprising of Formula (I): (I) wherein A, D and Q are described herein.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: August 17, 2021
    Assignee: CARDIO THERAPEUTICS PTY LTD
    Inventors: Herbert Treutlein, Jun Zeng, Ian Dixon, Ian James, James T. Palmer
  • HETEROCYCLIC INHIBITORS OF PCSK9
    Publication number: 20200207743
    Abstract: This application relates to chemical compounds which may act as inhibitors of, or which may otherwise modulate the activity of, PCSK9, or a pharmaceutically acceptable salt, solvate, prodrug or polymorph thereof, and to compositions and formulations comprising such compounds, and methods of using and making such compounds. Compounds include comprising of Formula (I): (I) wherein A, D and Q are described herein.
    Type: Application
    Filed: May 16, 2018
    Publication date: July 2, 2020
    Inventors: Herbert TREUTLEIN, Jun ZENG, Ian DIXON, Ian JAMES, James T. PALMER
  • FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS
    Publication number: 20170166555
    Abstract: The present invention relates to anti-tropomyosin compounds, processes for their preparation, and methods for treating or preventing a proliferative disease, preferably cancer, using compounds of the invention.
    Type: Application
    Filed: November 25, 2014
    Publication date: June 15, 2017
    Inventors: Ian James, Ian Dixon, John Feutrill, Anthony Cuzzupe, Herbert Treutlein, Jun Zeng, Tracy Nero, Peter Gunning